Correlation Between Plasma Oxidized Low Density Lipoprotein Levels And Postoperative Delirium
NCT ID: NCT03968887
Last Updated: 2019-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2019-05-20
2019-09-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Low-density lipoprotein (LDL) is a key molecule in the cholesterol transport mechanism and is easily oxidized to oxidized low-density lipoprotein (OxLDL). Oxidized low density lipoproteins are immunogenic and are also cytotoxic to endothelial cells. Some studies have shown that increased oxidative stress is one of the earliest changes in disease, and similar signs can be detected in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI), such as protein oxidation and lipids. An increase in the quality of the peroxidation index. For the study of anesthesiology, oxidative stress theory has long been recognized as one of the mechanisms of postoperative delirium. We have a hypothesis that plasma oxidized low-density lipoprotein levels are associated with postoperative delirium and can be used as an early warning marker for disease occurrence.
Based on clinical research data, we conducted a prospective cohort study to explore the correlation between plasma oxidized low-density lipoprotein levels and postoperative sputum, providing clinical prediction and diagnostic value.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factor of POD and POCD After Cardiac Surgery
NCT03635229
Correlation Analysis of POD and pNCD in Elderly Spinal Surgery Patients
NCT06466083
Associations of Postoperative Delirium With Perioperative Frailty Worsening and Their Combined Effect on 1-Year Mortality in Older Surgical Patients
NCT07259850
Plasma Proteomics in Patients With Postoperative Delirium
NCT05772026
Venous Congestion And Delirium After Cardiac Surgery
NCT07285187
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group
Patients with postoperative delirium.
plasma oxidized low-density lipoprotein levels
Detection of plasma oxidized low-density lipoprotein levels
Control group
Patients who have not had postoperative delirium.
plasma oxidized low-density lipoprotein levels
Detection of plasma oxidized low-density lipoprotein levels
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
plasma oxidized low-density lipoprotein levels
Detection of plasma oxidized low-density lipoprotein levels
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients in orthopedics, urology and general surgery.
Exclusion Criteria
* Preoperative dementia or cognitive dysfunction.
* Unable to communicate and cooperate with patients due to coma, language barrier or end-stage disease before surgery.
* ASA greater or equal to 4.
* Patients who have undergone neurosurgery and cardiac vascular surgery.
65 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-092
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.